Home › Cytomegalovirus Infections
Cytomegalovirus Infections clinical trials recruiting in the U.S.
12 studies for Cytomegalovirus Infections are recruiting participants at sites across the United States.
Cytomegalovirus (CMV) is a virus found worldwide. Most people with CMV don't need treatment. Learn about who is at risk and how to prevent infection.
By state
Recently updated studies
Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone
RecruitingPhase 3
1 Day – 30 Years · All sexes · Updated Sep 11, 2026 · NCT07225972Study Evaluating the Efficacy and Safety of Artesunate
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06853184R-MVST Cells for Treatment of Viral Infections in Children and Young Adults
RecruitingPhase 1
3 Months – 26 Years · All sexes · Updated Jul 30, 2026 · NCT06926894Ganciclovir Resistant/Refractory Cytomegalovirus Infection in SOT Recipients and HSCT Patients
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 15, 2026 · NCT05234723Letermovir (Prevymis) for CMV in Kidney and Pancreas Transplant Recipients
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jun 11, 2026 · NCT06407232R-MVST Cells for Treatment of Viral Infections
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jun 10, 2026 · NCT05183490T Cell Therapy of Opportunistic Cytomegalovirus Infection
RecruitingEarly phase 1
3 Months · All sexes · Updated Oct 22, 2025 · NCT02982902Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant
RecruitingPhase 1/2
Ages 1 to 21 · All sexes · Updated Oct 6, 2025 · NCT03354728Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
RecruitingPhase 1/2
1 Month – 65 Years · All sexes · Updated Aug 14, 2025 · NCT06909110Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
RecruitingPhase 2
1 Month – 79 Years · All sexes · Updated Aug 8, 2025 · NCT03266640Long-Term Outcomes of Children With Congenital CMV in New York State
RecruitingObservational study
0 Days – 1 Year · All sexes · Updated May 13, 2025 · NCT06226558Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
RecruitingPhase 4
Ages 18 to 75 · All sexes · Updated Apr 10, 2025 · NCT05626530From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.